TOWARD ACHIEVING OPTIMAL REPERFUSION - REVISITING THROMBOLYSIS

被引：3

作者：

BECKER, RC

机构：

[1] Thrombosis Research Center, Massachusetts Univ. Medical School, Worcester, MA

来源：

CORONARY ARTERY DISEASE | 1994年 / 5卷 / 08期

关键词：

CORONARY THROMBOLYSIS; REPERFUSION;

D O I：

10.1097/00019501-199408000-00011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：717 / 722

页数：6

共 52 条

[1] THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INFLUENCE OF DOSAGE REGIMENS IN RABBITS [J].

AGNELLI, G ;

BUCHANAN, MR ;

FERNANDEZ, F ;

HIRSH, J .

THROMBOSIS RESEARCH, 1985, 40 (06) :769-777

[2] THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION (TAMI-1) TRIAL - INFLUENCE OF INFARCT LOCATION ON ARTERIAL PATENCY, LEFT-VENTRICULAR FUNCTION AND MORTALITY [J].

BATES, ER ;

CALIFF, RM ;

STACK, RS ;

ARONSON, L ;

GEORGE, BS ;

CANDELA, RJ ;

KEREIAKES, DJ ;

ABBOTTSMITH, CW ;

ANDERSON, L ;

PITT, B ;

ONEILL, WW ;

TOPOL, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (01) :12-18

[3] A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL [J].

CANNON, CP ;

MCCABE, CH ;

HENRY, TD ;

SCHWEIGER, MJ ;

GIBSON, RS ;

MUELLER, HS ;

BECKER, RC ;

KLEIMAN, NS ;

HAUGLAND, JM ;

ANDERSON, JL ;

SHARAF, BL ;

EDWARDS, SJ ;

ROGERS, WJ ;

WILLIAMS, DO ;

BRAUNWALD, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) :993-1003

[4] RANDOMIZED ANGIOGRAPHIC TRIAL OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (ALTEPLASE) IN MYOCARDIAL-INFARCTION [J].

CARNEY, RJ ;

MURPHY, GA ;

BRANDT, TR ;

DALEY, PJ ;

PICKERING, E ;

WHITE, HJ ;

MCDONOUGH, TJ ;

VERMILYA, SK ;

TEICHMAN, SL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (01) :17-23

[5] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].

CHESEBRO, JH ;

KNATTERUD, G ;

ROBERTS, R ;

BORER, J ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

HILLIS, D ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTSON, T ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLERSON, J ;

WILLIAMS, DO ;

ZARET, BL ;

BRAUNWALD, E .

CIRCULATION, 1987, 76 (01) :142-154

[6] TIME COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUS OR INFUSION OF TISSUE PLASMINOGEN-ACTIVATOR IN A RABBIT JUGULAR VEIN-THROMBOSIS MODEL [J].

CLOZEL, JP ;

TSCHOPP, T ;

LUEDIN, E ;

HOLVOET, P .

CIRCULATION, 1989, 79 (01) :125-133

[7] CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].

COLLEN, D ;

TOPOL, EJ ;

TIEFENBRUNN, AJ ;

GOLD, HK ;

WEISFELDT, ML ;

SOBEL, BE ;

LEINBACH, RC ;

BRINKER, JA ;

LUDBROOK, PA ;

YASUDA, I ;

BULKLEY, BH ;

ROBISON, AK ;

HUTTER, AM ;

BELL, WR ;

SPADARO, JJ ;

KHAW, BA ;

GROSSBARD, EB .

CIRCULATION, 1984, 70 (06) :1012-1017

[8]

COLLEN D, 1984, J PHARMACOL EXP THER, V231, P146

[9]

DAVIES MJ, 1985, BRIT HEART J, V53, P363

[10]

Eisenberg Paul R., 1993, Journal of the American College of Cardiology, V21, p464A

← 1 2 3 4 5 6 →